Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ACRX [NASD]
AcelRx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.32 Insider Own0.70% Shs Outstand43.38M Perf Week-0.31%
Market Cap278.50M Forward P/E- EPS next Y-1.19 Insider Trans-92.21% Shs Float42.66M Perf Month-35.54%
Income-13.40M PEG- EPS next Q-0.24 Inst Own84.30% Short Float20.77% Perf Quarter-27.95%
Sales28.30M P/S9.84 EPS this Y60.90% Inst Trans-10.34% Short Ratio7.88 Perf Half Y-46.81%
Book/sh1.28 P/B5.02 EPS next Y-9.20% ROA-13.70% Target Price12.89 Perf Year-29.91%
Cash/sh2.13 P/C3.02 EPS next 5Y- ROE-21.70% 52W Range6.04 - 13.64 Perf YTD-43.24%
Dividend- P/FCF- EPS past 5Y11.10% ROI-7.60% 52W High-52.93% Beta1.81
Dividend %- Quick Ratio10.70 Sales past 5Y- Gross Margin- 52W Low6.29% ATR0.58
Employees44 Current Ratio10.70 Sales Q/Q-82.60% Oper. Margin-32.20% RSI (14)36.31 Volatility5.74% 7.15%
OptionableYes Debt/Eq0.44 EPS Q/Q48.90% Profit Margin-47.30% Rel Volume0.56 Prev Close6.78
ShortableYes LT Debt/Eq0.40 EarningsAug 11 AMC Payout- Avg Volume1.12M Price6.42
Recom2.00 SMA20-10.15% SMA50-28.65% SMA200-36.12% Volume634,286 Change-5.31%
28-Jul-14Reiterated RBC Capital Mkts Outperform $15 → $12
28-Jul-14Reiterated Mizuho Buy $20 → $15
28-Jul-14Downgrade Canaccord Genuity Buy → Hold
17-Apr-14Initiated Canaccord Genuity Buy $16
07-Jan-14Initiated RBC Capital Mkts Outperform $15
19-Dec-13Reiterated Mizuho Buy $18 → $20
17-Dec-13Reiterated MLV & Co Buy $15 → $16.50
17-Jul-13Reiterated Mizuho Neutral $13 → $18
04-Feb-13Initiated MLV & Co Buy $13
30-Jan-13Initiated Mizuho Buy $13
10-Oct-12Resumed Canaccord Genuity Buy $8
26-May-11Initiated Canaccord Genuity Buy $6
19-Aug-14 01:04PM  ACELRX PHARMACEUTICALS INC Financials EDGAR Online Financials
11-Aug-14 05:01PM  ACELRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:00PM  AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results PR Newswire
07:07AM  Q2 2014 AcelRx Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
08-Aug-14 07:00AM  AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events PR Newswire
07-Aug-14 07:00AM  AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Monday, August 11th, 2014. PR Newswire
01-Aug-14 08:16AM  AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session Zacks
07:00AM  4 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
29-Jul-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP
10:20AM  Today's Dead Cat Bounce Stock: AcelRx Pharmaceuticals (ACRX) at TheStreet
08:40AM  Top Analyst Upgrades and Downgrades: AcelRx, Alcoa, Costco, Lululemon, Walmart, Trulia and More at 24/7 Wall St.
28-Jul-14 06:05PM  Nasdaq stocks posting largest percentage decreases AP -41.00%
04:32PM  U.S. Stocks Little Changed on Mergers, Data Before Fed Bloomberg
04:15PM  Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap at MarketWatch
04:05PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
03:39PM  Stock market live blog: S&P 500, Dow on pace to end slightly higher; Herbalife earnings ahead at MarketWatch
02:35PM  AcelRx Pharma Plunges After FDA Rejects Device at Investor's Business Daily
02:26PM  Stock market live blog: Indexes turn higher; home builders lag at MarketWatch
01:55PM  Stock market live blog: S&P 500, Dow off session lows; home builder stocks hit hard at MarketWatch
01:32PM  Nasdaq stocks posting largest percentage decreases AP
01:25PM  Stock market live blog: S&P 500, Dow off session lows; home builder stocks hit hard at MarketWatch
12:43PM  Stock market live blog: S&P 500; Dow off session lows; home builder stocks hit hard at MarketWatch
12:13PM  Stock market live blog: S&P 500; Dow off session lows; Family Dollar Stores soars at MarketWatch
11:45AM  Stock market live blog: S&P 500 drops further as home sales miss; El Pollo Loco leaps again at MarketWatch
10:34AM  Stock market live blog: S&P 500 drops further as home sales miss; El Pollo Loco leaps again at MarketWatch
10:30AM  Stock market live blog: S&P 500 drops further as home sales miss; El Pollo Loco leaps again at MarketWatch
10:07AM  Why AcelRx Pharmaceuticals (ACRX) Stock Is Plummeting Today at TheStreet
10:00AM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:54AM  Stock market live blog: S&P 500 dips, while Nasdaq turns lower; Family Dollar, Trulia surge at MarketWatch
09:44AM  FDA Rejects AcelRx Painkiller Dispensing Device (Update) at TheStreet
09:35AM  [video] Mon., July 28: Family Dollar Among Stocks to Watch at MarketWatch
09:15AM  AcelRX Selling Off Sharply On FDA Reexamination Benzinga
08:48AM  AcelRx stock plunges after FDA rejects pain drug device Reuters
07:11AM  FDA Rejects AcelRx Painkiller Dispensing Device at TheStreet
06:58AM  AcelRx downgraded by Canaccord Genuity Briefing.com
27-Jul-14 01:25PM  FDA issues Complete Response Letter for AcelRx NDA for Zalviso at theflyonthewall.com
25-Jul-14 09:59PM  AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso PR Newswire +5.97%
02:52PM  Why AcelRx Pharmaceuticals Inc Stock Boomed at Motley Fool
24-Jul-14 11:49PM  AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso PR Newswire
23-Jul-14 09:01AM  Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release at Seeking Alpha +6.73%
07:52AM  Shorting AcelRx Into PDUFA: A Risky Proposition at Seeking Alpha
21-Jul-14 01:19PM  Nasdaq stocks posting largest percentage increases AP
07:06AM  AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session Zacks
18-Jul-14 01:20PM  Nasdaq stocks posting largest percentage increases AP +11.68%
07-Jul-14 10:13AM  AcelRx's Upcoming PDUFA And Trade Recommendations at Seeking Alpha
03:00AM  AcelRx and Grunenthal Announce Submission of European Marketing Authorization Application for ZALVISO PR Newswire
03-Jul-14 09:04AM  5 Stocks Spiking on Unusual Volume at TheStreet
02-Jul-14 08:30AM  AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month at Seeking Alpha
04:06AM  AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month at Seeking Alpha
19-Jun-14 07:00AM  AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference PR Newswire -5.10%
07:00AM  AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference
17-Jun-14 09:47AM  AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% Zacks
09:47AM  AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0%
16-Jun-14 04:35PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of EDGAR Online +8.95%
04:35PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of
03-Jun-14 07:00AM  Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management PR Newswire
07:00AM  Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management
02-Jun-14 04:31PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:31PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
04:13PM  AcelRx Pharmaceuticals Announces The Departure Of David Chung PR Newswire
04:13PM  AcelRx Pharmaceuticals Announces The Departure Of David Chung
29-May-14 08:00AM  AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference PR Newswire
08:00AM  AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
06:09AM  AcelRx management to meet with Piper Jaffray at theflyonthewall.com
06:09AM  AcelRx management to meet with Piper Jaffray
19-May-14 05:17PM  AcelRx files to sell 3.07M shares of common stock for holders at theflyonthewall.com
05:17PM  AcelRx files to sell 3.07M shares of common stock for holders
05:16PM  AcelRx files $150M mixed securities shelf at theflyonthewall.com
05:16PM  AcelRx files $150M mixed securities shelf
12:10PM  AcelRx management to meet with Jefferies at theflyonthewall.com
11:59AM  AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference PR Newswire
16-May-14 01:04PM  ACELRX PHARMACEUTICALS INC Financials EDGAR Online Financials
08-May-14 09:51PM  AcelRx Pharmaceuticals' (ACRX) CEO Richard King on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
05:13PM  ACELRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:36PM  AcelRx believes it has funds for operations at least through 2015 at theflyonthewall.com
04:34PM  AcelRx reports Q1 EPS (22c), consensus (23c) at theflyonthewall.com
04:05PM  AcelRx Pharmaceuticals Reports First Quarter 2014 Financial Results PR Newswire
07:07AM  Q1 2014 AcelRx Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
07-May-14 04:17PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Finan EDGAR Online
02-May-14 07:30AM  AcelRx Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Thursday, May 8, 2014 PR Newswire
01-May-14 07:30AM  AcelRx Pharmaceuticals Announces Zalviso and ARX-04 Data Presentations at the American Pain Society 33rd Annual Scientific Meeting PR Newswire
17-Apr-14 07:57AM  Coverage initiated on AcelRx by Canaccord Genuity Briefing.com
04-Apr-14 07:30AM  AcelRx Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference PR Newswire
01-Apr-14 05:05PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
25-Mar-14 05:03PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
07:30AM  AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer PR Newswire
21-Mar-14 01:04PM  ACELRX PHARMACEUTICALS INC Financials EDGAR Online Financials
17-Mar-14 05:19PM  ACELRX PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
07-Mar-14 04:45PM  AcelRx Pharmaceuticals to Participate at the 26th Annual Roth Conference PR Newswire -8.38%
05-Mar-14 05:01PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online +6.54%
04-Mar-14 01:43PM  Why AcelRx Pharmaceuticals, Inc. Shares Popped Today at Motley Fool +8.81%
03-Mar-14 11:29PM  AcelRx Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:29PM  AcelRx Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
04:05PM  AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 AcelRx Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
24-Feb-14 07:30AM  AcelRx Pharmaceuticals to Hold Fourth Quarter and Annual 2013 Financial Results Conference Call and Webcast on Monday, March 3, 2014 PR Newswire
14-Feb-14 08:30AM  Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity at Seeking Alpha
08:30AM  Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity
10-Feb-14 05:16PM  ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
09:35AM  Mallinckrodt Beats Q1 Earnings, Ups View Zacks
AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). Its principal product candidate is Zalviso, an investigational pre-programmed, non-invasive, handheld system that has completed Phase III clinical trials for the treatment of moderate-to-severe acute pain in adult patients in the hospital setting. The company is also developing ARX-04, a Sufentanil Single-Dose NanoTab, which has completed Phase II clinical trials for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in settings of acute pain, such as on the battlefield, in the emergency room, or in ambulatory care facilities. In addition, its product candidate pipeline consists of ARX-02, a Sufentanil NanoTab pain management system, which has completed Phase II clinical trials for the treatment of cancer patients who suffer from breakthrough pain (BTP); and ARX-03, a Sufentanil/Triazolam NanoTab, a Phase II clinical trials completed product designed to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a physician's office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WAN MARK ADirectorMar 10Sale12.36835,32710,324,642126,153Mar 11 02:34 PM
WAN MARK ADirectorMar 07Sale12.30164,6732,025,400137,403Mar 11 02:34 PM